| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $483,627 ) |
| | 2024 | 2024 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01DK131173 | Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis | 000 | 3 | NIH | 1/29/2024 | $483,628 |
| | 2024 | 2021 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R00CA208012 | Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling | 000 | 5 | NIH | 2/9/2024 | -$1 |
|
| Issue Date FY: 2023 ( Subtotal = $2,308,886 ) |
| | 2023 | 2023 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01HL152201 | Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias | 000 | 4 | NIH | 3/13/2023 | $629,459 |
| | 2023 | 2023 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01CA251397 | Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction | 000 | 4 | NIH | 6/2/2023 | $372,989 |
| | 2023 | 2023 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01DK131173 | Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis | 000 | 2 | NIH | 1/20/2023 | $540,254 |
| | 2023 | 2023 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01DE021104 | New upstream targets for HIF-1a-mediated regeneration in young and aged animals | 001 | 12 | NIH | 7/20/2023 | $35,130 |
| | 2023 | 2023 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01DE021104 | New upstream targets for HIF-1a-mediated regeneration in young and aged animals | 000 | 12 | NIH | 7/12/2023 | $731,054 |
|
| Issue Date FY: 2022 ( Subtotal = $1,924,540 ) |
| | 2022 | 2022 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01DK131173 | Probing an Unexplored Intracellular Pathway in Diabetes Pathogenesis | 000 | 1 | NIH | 1/7/2022 | $599,356 |
| | 2022 | 2022 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA251397 | Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction | 004 | 3 | NIH | 6/24/2022 | $384,512 |
| | 2022 | 2022 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01HL152201 | Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias | 000 | 3 | NIH | 6/17/2022 | $629,459 |
| | 2022 | 2021 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01CA251397 | Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction | 003 | 2 | NIH | 2/24/2022 | $2,193 |
| | 2022 | 2021 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA251397 | Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction | 001 | 2 | NIH | 1/21/2022 | $309,020 |
| | 2022 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01CA190952 | Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer | 000 | 5 | NIH | 11/23/2021 | $0 |
| | 2022 | 2016 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3450 | MONTGOMERY | USA | R01CA180070 | (PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK? | 000 | 5 | NIH | 10/1/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,583,568 ) |
| | 2021 | 2021 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R00CA208012 | Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling | 000 | 5 | NIH | 8/9/2021 | $249,000 |
| | 2021 | 2021 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01HL152201 | Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias | 000 | 2 | NIH | 3/29/2021 | $629,459 |
| | 2021 | 2021 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01DE021104 | New upstream targets for HIF-1a-mediated regeneration in young and aged animals | 000 | 11 | NIH | 8/13/2021 | $705,109 |
| | 2021 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA191191 | IDO2 Targeting in Pancreatic Cancer | 000 | 5 | NIH | 1/8/2021 | $0 |
| | 2021 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | UG1CA189852 | NCI Community Oncology Research Program (NCORP) Community Sites | 000 | 5 | NIH | 2/9/2021 | $0 |
| | 2021 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R56HL138103 | Novel Approaches to Pharmacologic Management of Life-Threatening Arrhythmias Associated with the J Wave Syndromes | 000 | 1 | NIH | 3/10/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,583,569 ) |
| | 2020 | 2020 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01HL152201 | Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias | 000 | 1 | NIH | 3/11/2020 | $629,459 |
| | 2020 | 2020 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01HL152201 | Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias | 001 | 1 | NIH | 7/2/2020 | $0 |
| | 2020 | 2020 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R00CA208012 | Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling | 001 | 4 | NIH | 8/26/2020 | $246,478 |
| | 2020 | 2020 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01DE021104 | New upstream targets for HIF-1a-mediated regeneration in young and aged animals | 000 | 10 | NIH | 8/6/2020 | $705,109 |
| | 2020 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R00CA208012 | Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling | 000 | 3 | NIH | 1/19/2020 | $2,523 |
| | 2020 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R21AG055047 | New Drug Discovery Paradigms for Synucleinopathies | 000 | 2 | NIH | 5/18/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,699,898 ) |
| | 2019 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R00CA208012 | Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling | 000 | 3 | NIH | 9/6/2019 | $249,000 |
| | 2019 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA191191 | IDO2 Targeting in Pancreatic Cancer | 000 | 5 | NIH | 6/17/2019 | $379,675 |
| | 2019 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA190952 | Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer | 000 | 5 | NIH | 6/24/2019 | $366,114 |
| | 2019 | 2019 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01DE021104 | New upstream targets for HIF-1a-mediated regeneration in young and aged animals | 000 | 9 | NIH | 7/24/2019 | $705,109 |
| | 2019 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R56HL138103 | Novel Approaches to Pharmacologic Management of Life-Threatening Arrhythmias Associated with the J Wave Syndromes | 000 | 1 | NIH | 12/18/2018 | $0 |
| | 2019 | 2017 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R21AI119368 | Comprehensive functional assesment of the human antibody response to Enterovirus 71 | 000 | 2 | NIH | 8/27/2019 | $0 |
| | 2019 | 2017 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R21CA198657 | Immunotoxins based on the IgG response to autologous antigens in cancer patients | 000 | 2 | NIH | 7/30/2019 | $0 |
| | 2019 | 2016 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA180070 | (PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK? | 000 | 5 | NIH | 12/6/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $2,728,864 ) |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R21AG055047 | New Drug Discovery Paradigms for Synucleinopathies | 000 | 2 | NIH | 4/27/2018 | $201,111 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R21AG055047 | New Drug Discovery Paradigms for Synucleinopathies | 001 | 2 | NIH | 6/22/2018 | -$201,111 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R21AG055047 | New Drug Discovery Paradigms for Synucleinopathies | 001 | 2 | NIH | 6/22/2018 | $201,111 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R56HL138103 | Novel Approaches to Pharmacologic Management of Life-Threatening Arrhythmias Associated with the J Wave Syndromes | 000 | 1 | NIH | 9/11/2018 | $412,500 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | UG1CA189852 | NCI Community Oncology Research Program (NCORP) Community Sites | 000 | 5 | NIH | 7/31/2018 | $612,003 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | UG1CA189852 | NCI Community Oncology Research Program (NCORP) Community Sites | 001 | 5 | NIH | 9/12/2018 | $29,285 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01DE021104 | New upstream targets for HIF-1a-mediated regeneration in young and aged animals | 000 | 8 | NIH | 8/9/2018 | $705,109 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA190952 | Polyamine-stimulated stem cell recruitment in arsenic-induced skin cancer | 000 | 4 | NIH | 6/4/2018 | $377,438 |
| | 2018 | 2018 | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | 100 E LANCASTER AVE | WYNNEWOOD | PA | 19096-3434 | MONTGOMERY | USA | R01CA191191 | IDO2 Targeting in Pancreatic Cancer | 000 | 4 | NIH | 7/19/2018 | $391,418 |
|
|
